920968-53-2 Usage
Molecular structure
1H-Pyrazole-3-carbonyl chloride,
Contains a pyrazole ring
A five-membered heterocyclic ring with one nitrogen atom and one carbonyl group.
Carbonyl chloride group attached
A chlorine atom attached to a carbonyl group (C=O), enhancing reactivity and potential for further chemical reactions.
2,4-Dichlorophenyl group
A phenyl ring with two chlorine atoms attached at the 2nd and 4th positions, contributing to the compound's lipophilicity and potential biological activity.
4,5-Dihydro
The molecule has two additional hydrogen atoms in a six-membered ring structure, which may influence its stability and reactivity.
5-(4-Methoxyphenyl) group
A phenyl ring with a methoxy group (-OCH3) attached at the 4th position, potentially contributing to the compound's solubility and bioavailability.
Potential applications in pharmaceutical research and development
The compound's unique structure and functional groups make it a promising candidate for the synthesis of new drugs or as a building block for biologically active compounds.
Requires further investigation and testing
The specific properties and potential uses of 1H-Pyrazole-3-carbonyl chloride,
1-(2,4-dichlorophenyl)-4,5-dihydro-5-(4-methoxyphenyl)- need to be explored through experimental studies and analysis.
Check Digit Verification of cas no
The CAS Registry Mumber 920968-53-2 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 9,2,0,9,6 and 8 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 920968-53:
(8*9)+(7*2)+(6*0)+(5*9)+(4*6)+(3*8)+(2*5)+(1*3)=192
192 % 10 = 2
So 920968-53-2 is a valid CAS Registry Number.
920968-53-2Relevant academic research and scientific papers
Substituted pyrazoline for preventing weight gain
-
Page/Page column 120, (2008/12/07)
The present invention relates to an active substance combination comprising at least one substituted pyrazoline compound and at least one drug, known to produce weight-gain as a side effect, a medicament comprising said active substance combination, a pharmaceutical formulation comprising said active substance combination and the use of said active substance combination for the manufacture of a medicament.
Active substance combination for the treatment of diabetes
-
Page/Page column 120, (2008/12/07)
The present invention relates to an active substance combination comprising at least one substituted pyrazoline compound and at least one drug, used to treat diabetes, a medicament comprising said active substance combination, a pharmaceutical formulation
